JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Saturday, July 26, 2025

Vaccine distribution concerns

by

1618 days ago
20210219

Es­cap­ing the sti­fling grip of COVID-19 re­quires herd im­mu­ni­ty which should be the main ob­jec­tive of T&T’s pub­lic health au­thor­i­ties. That means en­sur­ing that enough peo­ple de­vel­op im­mu­ni­ty, ei­ther from vac­ci­na­tion or past in­fec­tion, to stop the coro­n­avirus from eas­i­ly jump­ing from per­son to per­son.

A well planned and care­ful­ly im­ple­ment­ed vac­ci­na­tion pro­gramme aimed at im­mu­niz­ing at least 70 per cent of the pop­u­la­tion seems the ob­vi­ous choice, which is why it is per­plex­ing that greater ef­forts aren’t be­ing made to se­cure more vac­cine dos­es.

The na­tion has been hear­ing from Health Min­is­ter Ter­rence Deyals­ingh that the main op­tion is the CO­V­AX fa­cil­i­ty from which an ini­tial 100,000 to 120,000 dos­es of the Ox­ford-As­traZeneca COVID-19 vac­cine has al­ready been or­dered. How­ev­er, those vac­cines will be enough for just about 50,000 peo­ple—way off the num­bers re­quired in our pop­u­la­tion of 1.4 mil­lion for herd im­mu­ni­ty.

Apart from that, save for the 2,000 dos­es that were a gift from Bar­ba­dos, there seem to be no con­crete arrange­ments to se­cure ad­di­tion­al vac­cines.

In­stead, there ap­pears to be some ret­i­cence about go­ing the route of the Bar­ba­dos and Do­mini­ca gov­ern­ments which have al­ready ob­tained As­traZeneca vac­cines. Their con­sign­ments of the made in In­dia Co­v­ishield vac­cines ar­rived this week.

T&T, on the oth­er hand, has been slow off the start­ing blocks and on­ly on Wednes­day start­ed ad­min­is­ter­ing first dos­es to front­line health work­ers from the vac­cines gift­ed by the Mia Mot­t­ley ad­min­is­tra­tion in Bar­ba­dos.

Yes­ter­day, even as Prime Min­is­ter Dr Kei­th Row­ley was be­ing praised by Dr Tedros Ghe­breye­sus, Di­rec­tor-Gen­er­al of the World Health Or­ga­ni­za­tion (WHO), for his han­dling of the COVID-19 pan­dem­ic, in­for­ma­tion was com­ing to hand of some hes­i­tan­cy in ac­cept­ing vac­cines from In­dia.

Talks have on­ly just be­gun with In­dia about get­ting vac­cines from that coun­try, nev­er mind that our na­tions have en­joyed al­most six decades of strong diplo­mat­ic re­la­tions.

The ex­tra cau­tion in seek­ing WHO val­i­da­tion be­fore ful­ly ex­plor­ing In­dia’s As­traZeneca op­tion seems un­nec­es­sary when one con­sid­ers that In­dia is a vac­cine pow­er­house, pro­duc­ing 60 per cent of the world's vac­cines. The Co­v­ishield vac­cine is man­u­fac­tured by Bharat Biotech, a vac­cine mak­er with a port­fo­lio of 16 vac­cines and ex­ports to 123 coun­tries.

T&T needs to step up its vac­cine game, par­tic­u­lar­ly giv­en per­sis­tent con­cerns about dis­crim­i­na­tion in dis­tri­b­u­tions around the world. To date, on­ly 10 coun­tries have ad­min­is­tered 75 per cent of all COVID-19 vac­ci­na­tions.

Ear­li­er this week, Unit­ed Na­tions Sec­re­tary-Gen­er­al An­to­nio Guter­res spoke out about “wild­ly un­even and un­fair” dis­tri­b­u­tion and called for an ur­gent Glob­al Vac­ci­na­tion Plan to en­sure a more eq­ui­table sys­tem.

In these cir­cum­stances risks end­ing up at the back of the queue if it doesn’t step up its vac­cine ac­qui­si­tion game. There is in-coun­try ca­pac­i­ty to store sub­stan­tial quan­ti­ties of dos­es—more than 300,000 at 2 to 8 de­grees, 200,000 at -20 de­grees and 200,000 at -70 de­grees Cel­sius—so there is no need to set­tle for a small amount.

Too much hes­i­ta­tion on the vac­cine front could be risky.


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored